Skip to main content
Top
Published in: European Radiology 2/2017

01-02-2017 | Neuro

Usefulness of colour Doppler flow imaging in the management of lacrimal gland lesions

Authors: A. Lecler, M. Boucenna, F. Lafitte, P. Koskas, E. Nau, P. V. Jacomet, O. Galatoire, S. Morax, M. Putterman, F. Mann, F. Héran, J. C. Sadik, H. Picard, O. Bergès

Published in: European Radiology | Issue 2/2017

Login to get access

Abstract

Objective

To assess the role of colour Doppler flow imaging (CDFI) in the diagnosis and management of lacrimal fossa lesions.

Methods

Institutional ethical committee approval was obtained. Fifty-one patients with 62 lacrimal fossa lesions were retrospectively included from 2003–2015. All patients underwent conventional ultrasonography and CDFI, with a qualitative and quantitative analysis of the vascularization. All patients had lacrimal gland surgery. Definitive diagnosis was based on pathological examination.

Results

The study included 47 non-epithelial lesions (NEL) and 15 epithelial lesions (EL), with 24 (39 %) malignant lesions and 38 (61 %) benign lesions. NEL were significantly more likely to present with septa (p < 0.001), hypoechogenicity (p < 0.001), high vascular intensity (p < 0.001), both central and peripheral vascularization (p < 0.001), tree-shape vascularization (p < 0.05) and a low resistance index (RI) (p < 0.0001). EL were significantly more likely to present with the presence of cysts (p < 0.001), and a higher RI. Receiver operating characteristic curves identified a RI value of 0.72 as the best cut-off to differentiate NEL from EL, with a sensitivity and specificity of 100 %.

Conclusion

CDFI is a valuable tool in the differential diagnosis of lacrimal fossa lesions. Resistance index measurement enables substantial distinction between EL and NEL, thus providing crucial data for surgical management.

Key Points

CDFI is a valuable tool in lacrimal fossa lesions.
Resistance Index measurement enables substantial distinction between epithelial and non-epithelial lesions.
Management of patients becomes more appropriate.
Literature
1.
go back to reference Shields JA, Shields CL, Scartozzi R (2004) Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology 111:997–1008CrossRefPubMed Shields JA, Shields CL, Scartozzi R (2004) Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology 111:997–1008CrossRefPubMed
2.
go back to reference Levecq L, De Potter P, Guagnini A-P (2005) Epidemiology of ocular and orbital lesions referred to an ocular oncology center. J Fr Ophtalmol 28:840–844CrossRefPubMed Levecq L, De Potter P, Guagnini A-P (2005) Epidemiology of ocular and orbital lesions referred to an ocular oncology center. J Fr Ophtalmol 28:840–844CrossRefPubMed
4.
go back to reference Hesselink JR, Davis KR, Dallow RL et al (1979) Computed tomography of masses in the lacrimal gland region. Radiology 131:143–147CrossRefPubMed Hesselink JR, Davis KR, Dallow RL et al (1979) Computed tomography of masses in the lacrimal gland region. Radiology 131:143–147CrossRefPubMed
5.
go back to reference Kapur R, Sepahdari AR, Mafee MF et al (2009) MR imaging of orbital inflammatory syndrome, orbital cellulitis, and orbital lymphoid lesions: the role of diffusion-weighted imaging. AJNR Am J Neuroradiol 30:64–70CrossRefPubMed Kapur R, Sepahdari AR, Mafee MF et al (2009) MR imaging of orbital inflammatory syndrome, orbital cellulitis, and orbital lymphoid lesions: the role of diffusion-weighted imaging. AJNR Am J Neuroradiol 30:64–70CrossRefPubMed
6.
go back to reference Zhang F, Sha Y, Qian J et al (2014) Role of magnetic resonance diffusion-weighted imaging in differentiating lacrimal masses. J Magn Reson Imaging 40:641–648CrossRefPubMed Zhang F, Sha Y, Qian J et al (2014) Role of magnetic resonance diffusion-weighted imaging in differentiating lacrimal masses. J Magn Reson Imaging 40:641–648CrossRefPubMed
7.
go back to reference Politi LS, Forghani R, Godi C et al (2010) Ocular adnexal lymphoma: diffusion-weighted mr imaging for differential diagnosis and therapeutic monitoring. Radiology 256:565–574CrossRefPubMed Politi LS, Forghani R, Godi C et al (2010) Ocular adnexal lymphoma: diffusion-weighted mr imaging for differential diagnosis and therapeutic monitoring. Radiology 256:565–574CrossRefPubMed
8.
go back to reference Vaidhyanath R, Kirke R, Brown L, Sampath R (2008) Lacrimal fossa lesions: pictorial review of CT and MRI features. Orbit 27:410–418CrossRefPubMed Vaidhyanath R, Kirke R, Brown L, Sampath R (2008) Lacrimal fossa lesions: pictorial review of CT and MRI features. Orbit 27:410–418CrossRefPubMed
9.
go back to reference Jung WS, Ahn KJ, Park MR et al (2007) The radiological spectrum of orbital pathologies that involve the lacrimal gland and the lacrimal fossa. Korean J Radiol 8:336–342CrossRefPubMedPubMedCentral Jung WS, Ahn KJ, Park MR et al (2007) The radiological spectrum of orbital pathologies that involve the lacrimal gland and the lacrimal fossa. Korean J Radiol 8:336–342CrossRefPubMedPubMedCentral
10.
go back to reference Erickson SJ, Hendrix LE, Massaro BM et al (1989) Color Doppler flow imaging of the normal and abnormal orbit. Radiology 173:511–516CrossRefPubMed Erickson SJ, Hendrix LE, Massaro BM et al (1989) Color Doppler flow imaging of the normal and abnormal orbit. Radiology 173:511–516CrossRefPubMed
11.
go back to reference Pichot O, Gonzalvez B, Franco A, Mouillon M (1996) Color Doppler ultrasonography in the study of orbital and ocular vascular diseases. J Fr Ophtalmol 19:19–31PubMed Pichot O, Gonzalvez B, Franco A, Mouillon M (1996) Color Doppler ultrasonography in the study of orbital and ocular vascular diseases. J Fr Ophtalmol 19:19–31PubMed
12.
go back to reference Jain R, Sawhney S, Berry M (1992) Real-time sonography of orbital tumours, Colour Doppler characterization: initial experience. Acta Ophthalmol Suppl 46–49 Jain R, Sawhney S, Berry M (1992) Real-time sonography of orbital tumours, Colour Doppler characterization: initial experience. Acta Ophthalmol Suppl 46–49
13.
go back to reference Neudorfer M, Leibovitch I, Stolovitch C et al (2004) Intraorbital and periorbital tumors in children--value of ultrasound and color Doppler imaging in the differential diagnosis. Am J Ophthalmol 137:1065–1072CrossRefPubMed Neudorfer M, Leibovitch I, Stolovitch C et al (2004) Intraorbital and periorbital tumors in children--value of ultrasound and color Doppler imaging in the differential diagnosis. Am J Ophthalmol 137:1065–1072CrossRefPubMed
14.
15.
go back to reference Iveković R, Lovrencić-Huzjan A, Novak-Laus K, Demarin V (2000) Value of color-Doppler imaging in diagnosis of intrabulbar and intraorbital tumors. Coll Antropol 24:205–210PubMed Iveković R, Lovrencić-Huzjan A, Novak-Laus K, Demarin V (2000) Value of color-Doppler imaging in diagnosis of intrabulbar and intraorbital tumors. Coll Antropol 24:205–210PubMed
16.
go back to reference Spierer O, Neudorfer M, Leibovitch I et al (2012) Colour Doppler ultrasound imaging findings in paediatric periocular and orbital haemangiomas. Acta Ophthalmol 90:727–732CrossRefPubMed Spierer O, Neudorfer M, Leibovitch I et al (2012) Colour Doppler ultrasound imaging findings in paediatric periocular and orbital haemangiomas. Acta Ophthalmol 90:727–732CrossRefPubMed
17.
go back to reference Verity DH, Restori M, Rose GE (2006) Natural history of periocular capillary haemangiomas: changes in internal blood velocity and lesion volume. Eye (Lond) 20:1228–1237CrossRef Verity DH, Restori M, Rose GE (2006) Natural history of periocular capillary haemangiomas: changes in internal blood velocity and lesion volume. Eye (Lond) 20:1228–1237CrossRef
18.
go back to reference Ehrlich R, Harris A, Siesky BA et al (2011) Repeatability of retrobulbar blood flow velocity measured using color Doppler imaging in the Indianapolis Glaucoma Progression Study. J Glaucoma 20:540–547CrossRefPubMed Ehrlich R, Harris A, Siesky BA et al (2011) Repeatability of retrobulbar blood flow velocity measured using color Doppler imaging in the Indianapolis Glaucoma Progression Study. J Glaucoma 20:540–547CrossRefPubMed
20.
go back to reference Reese AB (1956) The treatment of expanding lesions of the orbit with particular regard to those arising in the lacrimal gland; the seventh Arthur J. Bedell lecture. Am J Ophthalmol 41:3–11CrossRefPubMed Reese AB (1956) The treatment of expanding lesions of the orbit with particular regard to those arising in the lacrimal gland; the seventh Arthur J. Bedell lecture. Am J Ophthalmol 41:3–11CrossRefPubMed
22.
go back to reference Shields CL, Shields JA, Eagle RC, Rathmell JP (1989) Clinicopathologic review of 142 cases of lacrimal gland lesions. Ophthalmology 96:431–435CrossRefPubMed Shields CL, Shields JA, Eagle RC, Rathmell JP (1989) Clinicopathologic review of 142 cases of lacrimal gland lesions. Ophthalmology 96:431–435CrossRefPubMed
24.
go back to reference Eldesouky MA, Elbakary MA, Sabik S, Shareef MM (2014) Lacrimal fossa lesions: a review of 146 cases in Egypt. Clin Ophthalmol 8:1603–1609PubMedPubMedCentral Eldesouky MA, Elbakary MA, Sabik S, Shareef MM (2014) Lacrimal fossa lesions: a review of 146 cases in Egypt. Clin Ophthalmol 8:1603–1609PubMedPubMedCentral
25.
26.
go back to reference Font RL, Smith SL, Bryan RG (1998) Malignant epithelial tumors of the lacrimal gland: a clinicopathologic study of 21 cases. Arch Ophthalmol 116:613–616CrossRefPubMed Font RL, Smith SL, Bryan RG (1998) Malignant epithelial tumors of the lacrimal gland: a clinicopathologic study of 21 cases. Arch Ophthalmol 116:613–616CrossRefPubMed
27.
go back to reference Teo L, Seah LL, Choo CT et al (2013) A survey of the histopathology of lacrimal gland lesions in a tertiary referral centre. Orbit 32:1–7CrossRefPubMed Teo L, Seah LL, Choo CT et al (2013) A survey of the histopathology of lacrimal gland lesions in a tertiary referral centre. Orbit 32:1–7CrossRefPubMed
28.
go back to reference Ng DS-C, Chan E, Yau K, Chan CW-N (2011) Clinicopathological survey of 23 patients with lacrimal fossa lesions in Hong Kong. Int J Ophthalmol 4:311–313PubMedPubMedCentral Ng DS-C, Chan E, Yau K, Chan CW-N (2011) Clinicopathological survey of 23 patients with lacrimal fossa lesions in Hong Kong. Int J Ophthalmol 4:311–313PubMedPubMedCentral
29.
go back to reference von Holstein SL (2013) Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics. Acta Ophthalmol 6:1–28CrossRef von Holstein SL (2013) Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics. Acta Ophthalmol 6:1–28CrossRef
31.
32.
go back to reference Auran J, Jakobiec FA, Krebs W (1988) Benign mixed tumor of the palpebral lobe of the lacrimal gland. Clinical diagnosis and appropriate surgical management. Ophthalmology 95:90–99CrossRefPubMed Auran J, Jakobiec FA, Krebs W (1988) Benign mixed tumor of the palpebral lobe of the lacrimal gland. Clinical diagnosis and appropriate surgical management. Ophthalmology 95:90–99CrossRefPubMed
33.
go back to reference Lai T, Prabhakaran VC, Malhotra R, Selva D (2009) Pleomorphic adenoma of the lacrimal gland: is there a role for biopsy? Eye (Lond) 23:2–6CrossRef Lai T, Prabhakaran VC, Malhotra R, Selva D (2009) Pleomorphic adenoma of the lacrimal gland: is there a role for biopsy? Eye (Lond) 23:2–6CrossRef
34.
go back to reference Tse DT, Benedetto P, Dubovy S et al (2006) Clinical analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma. Am J Ophthalmol 141:44–53CrossRefPubMed Tse DT, Benedetto P, Dubovy S et al (2006) Clinical analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma. Am J Ophthalmol 141:44–53CrossRefPubMed
35.
go back to reference Le Tourneau C, Razak ARA, Levy C et al (2011) Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland. Br J Ophthalmol 95:1483–1489CrossRefPubMed Le Tourneau C, Razak ARA, Levy C et al (2011) Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland. Br J Ophthalmol 95:1483–1489CrossRefPubMed
37.
go back to reference Dellafiore C, Lava M, Verticchio Vercellin AC et al (2015) Reproducibility of retrobulbar blood flow velocity measurements in normal subjects using two different CDI devices. Radiol Med. doi:10.1007/s11547-015-0522-4 PubMed Dellafiore C, Lava M, Verticchio Vercellin AC et al (2015) Reproducibility of retrobulbar blood flow velocity measurements in normal subjects using two different CDI devices. Radiol Med. doi:10.​1007/​s11547-015-0522-4 PubMed
Metadata
Title
Usefulness of colour Doppler flow imaging in the management of lacrimal gland lesions
Authors
A. Lecler
M. Boucenna
F. Lafitte
P. Koskas
E. Nau
P. V. Jacomet
O. Galatoire
S. Morax
M. Putterman
F. Mann
F. Héran
J. C. Sadik
H. Picard
O. Bergès
Publication date
01-02-2017
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 2/2017
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-016-4438-8

Other articles of this Issue 2/2017

European Radiology 2/2017 Go to the issue